Singapore Medical Group: Welcomes Leading Korean Healthcare Group CHA As Strategic Shareholder With S$15 Million Investment.

17 Feb 2017 07:50

SMG will use the bulk of the proceeds to aggressively explore further organic and inorganic growth opportunities in Singapore and the Southeast Asian region. Marking its inaugural investment in Southeast Asia, CHA to emerge as 4th largest shareholder in SMG with a 8.8% stake via subscription of 30.0 million new ordinary shares at S$0.50 per share. Taps CHA's highly regarded specialisations in Obstetrics & Gynecology and reproductive medicine for cross-border synergies with near-term projects in Vietnam, Singapore and other key Asian markets, anchoring SMG's position as a pan-Asia private healthcare specialist...

Attachments: